Informing the Next Generation of PD Therapies
Foundation-funded researcher Alexandra Nelson, M.D., Ph.D., is using a groundbreaking technology and a $300,000 grant to improve Parkinson's therapies.Learn More
What's New in Research?
What's new in PD research and treatment? In this report, James Beck, Ph.D., VP, Scientific Affairs discusses recent trends and discoveries.
Celebrate Spring New York
Wednesday, April 5 (New York, NY)
Enjoy a night of cocktails, hors d’oeuvres, dancing with music by DJ Brenda Black, dessert and a live auction to benefit Parkinson's research.
FDA Approves Safinamide (Xadago®) as an Add-on Treatment for Parkinson’s
March 22, 2017
The Parkinson’s Foundation alerts the community that the US Food and Drug Administration (FDA) has approved safinamide tablets (Xadago®) as an add-on treatment for people with Parkinson’s who are currently taking carbidopa/levodopa and experiencing “off” episodes.